About
Our Name
Mission
Values
Leadership
Board of Directors
Investors
Newsroom
Press Releases
In the News
Events
Contact
About
Our Name
Mission
Values
Leadership
Board of Directors
Investors
Newsroom
Press Releases
In the News
Events
Contact
IN THE NEWS
Arena Pharma In-Licenses Aristea’s CXCR2 Antagonist For Immune-Mediated Inflammatory Disease
July 28, 2021
Original Article Link
2023 © Copyright. Aristea Therapeutics. All Rights Reserved.
